Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–2 of 2 results
Advanced filters: Author: Sylvia Escher Clear advanced filters
  • Thirteen pharmaceutical companies have shared and integrated preclinical and clinical data for creating computational resources that enhance translational drug safety assessment.

    • Ferran Sanz
    • François Pognan
    • David Wilkinson
    Comments & Opinion
    Nature Reviews Drug Discovery
    Volume: 22, P: 605-606
  • The sharing of legacy preclinical safety data among pharmaceutical companies and its integration with other information sources offers unprecedented opportunities to improve the early assessment of drug safety. Here, we discuss the experience of the eTOX project, which was established through the Innovative Medicines Initiative to explore this possibility.

    • Ferran Sanz
    • François Pognan
    • Ismael Zamora
    Comments & Opinion
    Nature Reviews Drug Discovery
    Volume: 16, P: 811-812